BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 16, 2023
Discovery & Translation

NONO-targeted small molecules for prostate cancer, innovations in single cell methods and more

BioCentury’s roundup of translational news
BioCentury | Jul 18, 2019
Financial News

Kronos parlays diverse pipeline into $105M series A

BioCentury | Sep 20, 2018
Emerging Company Profile

Recalcitrant Targets

How Kronos’ small molecule microarrays could help drug the undruggable
BioCentury | May 30, 2018
Distillery Therapeutics

Cancer

BioCentury | Oct 31, 2017
Distillery Therapeutics

Cancer

BioCentury | Aug 1, 2016
Clinical News

Galeterone: Phase III discontinued

BioCentury | Jul 26, 2016
Clinical News

Tokai ending galeterone study

BioCentury | Jul 20, 2015
Clinical News

Galeterone: Phase III started

BioCentury | Apr 13, 2015
Company News

Qiagen N.V, Tokai deal

Items per page:
1 - 10 of 13